公司資料

Elevance Health 股價、新聞與催化劑

股票代碼:
ELV
交易所:
NYSE
產業:
Biopharma
所在地:
United States

股票表現

381.67 USD (-1.84%)

收盤價

最後更新: 2026年10月1日

84.5B USD

市值

股價為何變動

截至 2026年10月1日,ELV 下跌 1.84%,收於 $381.67。目前新聞監測窗口內未發現新的同公司新聞。

公司概覽

Diversified Health Benefits Company

Elevance Health provides health insurance and related healthcare services across commercial, Medicare, Medicaid, individual, and federal employee markets. Its scale combines regulated health-plan operations with pharmacy, behavioral-health, clinical, and complex-care capabilities.

Health Benefits Segment

The Health Benefits business includes Individual, Employer Group risk-based and fee-based plans, BlueCard, Medicare, Medicaid, and the Federal Employee Program. The segment earns premium and administrative revenue while managing provider networks, medical utilization, and benefit costs.

Carelon Health Services Platform

Carelon houses Elevance Health's diversified healthcare services, including CarelonRx and Carelon Services. These operations provide pharmacy-benefit and specialty-pharmacy services, behavioral health, care delivery, utilization management, and value-based solutions to Elevance members and external customers.

Integrated Whole-Health Model

The company seeks to connect medical benefits, pharmacy, behavioral care, home health, and complex-care support around the same consumer. Data and digital capabilities are used to coordinate interventions, support providers, and manage the cost and quality of care across the member journey.

Large National Consumer Base

Elevance Health's companies serve approximately 104 million consumers through health plans and healthcare services. Its broad membership, provider relationships, and benefit data create a large distribution base for Carelon solutions and population-health programs.

未來催化劑

    近期新聞

    新聞標題由機器翻譯,詳情為英文原文。

      相似股票

      商業成熟度、治療領域或催化劑模式相近的同業公司。